menu
    • menu

    Company profile for Inversago Pharma

    NEW Drugs in Dev: 3
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    As a specialty therapeutics, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of Prader-Willi Syndrome, non-alcoholic steatohepatitis (NASH), type 1 diabetes and other metabolic disorders such as diabetic nephropathy. The mechanism of action of Inversago’s molecules addresses the safety limits associated to firs...
    As a specialty therapeutics, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of Prader-Willi Syndrome, non-alcoholic steatohepatitis (NASH), type 1 diabetes and other metabolic disorders such as diabetic nephropathy. The mechanism of action of Inversago’s molecules addresses the safety limits associated to first generation, centrally-acting CB1 blockers, allowing the company to exploit their full medical potential.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Inversago PharmaCanada Flag
    Country
    Country
    Canada
    Address
    Address
    1 Place Ville Marie Suite 1670 Montreal, Quebec H3B 2B6 Canada
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://inversago.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inversago was working toward a potential 2024 IPO
    Inversago was working toward a potential 2024 IPO

    22 Aug 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/novo-nordisk-swooped-in-on-inversago-before-the-canadian-biotech-could-test-the-ipo-waters/

    Kyle LaHucik ENDPTS
    22 Aug 2023
    Share Share
    Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
    Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion

    11 Aug 2023

    // CNBC

    https://www.cnbc.com/2023/08/10/novo-nordisk-to-acquire-inversago-pharma-canadian-obesity-drug-maker-.html

    CNBC
    11 Aug 2023
    Share Share
    Inversago Pharma Presents Data from Phase 1b Trial of INV-202
    Inversago Pharma Presents Data from Phase 1b Trial of INV-202

    23 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230623384277/en

    BUSINESSWIRE
    23 Jun 2023
    Share Share
    Inversago Pharma to Present Data from Phase 1b Trial of INV-202
    Inversago Pharma to Present Data from Phase 1b Trial of INV-202

    08 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230608005236/en

    BUSINESSWIRE
    08 Jun 2023
    Share Share
    Inversago Pharma Announces New Data to be Presented at the 2023 Conference
    Inversago Pharma Announces New Data to be Presented at the 2023 Conference

    22 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230522005106/en

    BUSINESSWIRE
    22 May 2023
    Share Share
    Inversago to Participate at the 2023 SVB Securities Global Biopharma Conference
    Inversago to Participate at the 2023 SVB Securities Global Biopharma Conference

    24 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230124005328/en

    BUSINESSWIRE
    24 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search